Aradigm Corp (ARDM.OQ)
8 Dec 2017
Fri, Dec 1 2017
* ARADIGM ANNOUNCES FDA ADVISORY COMMITTEE MEETING FOR LINHALIQ
* Aradigm Corp files for common stock offering of up to $20 million - SEC filing Source text: (http://bit.ly/2lOJdUD) Further company coverage:
* Aradigm corp - qtrly rev $2.7 million versus $50,000 Source text for Eikon: Further company coverage:
* Aradigm Corp presents analysis of results for phase 3 orbit-3 and orbit-4 clinical trials - sec filing
BRIEF-Aradigm says Laurence Lytton reports 5.1 pct passive stake in co as of May 31, 2017 - sec filing
* Laurence W.Lytton reports a 5.1 percent passive stake in aradigm corp as of may 31, 2017 - sec filing Source text for Eikon: Further company coverage:
- 3 Things In Biotech You Should Learn Today: December 3, 2017
- Your Daily Pharma Scoop: Dynavax Beyond Heplisav-B, Novartis' Cosentyx, Shire Granted ODD
- Quinolones And The Adcom Of Doom: Can Aradigm Achieve The Holy Grail Of Monopoly?
- Aradigm Corporation (ARDM) Presents At Ladenburg Thalmann 2017 Healthcare Conference - Slideshow
- Your Daily Pharma Scoop: Alnylam's Big Win, Aradigm NDA And Rating, EXEL And AZN Japan Expansions
- Aradigm: Hidden Binary Event Or Russian Roulette (With The FDA Spinning The Chamber)?